Physician profile
Ankit Gupta
NPI 1023324555
$13,196.60
in general payments reported to CMS, 2019-2025
47 companies · $5,606 in 2025
The $5,606 reported for 2025 was more than what 89% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,999 · 2020: $542 · 2021: $359 · 2022: $1,530 · 2023: $1,458 · 2024: $1,702 · 2025: $5,606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,776 · Education: $2,559 · Travel and Lodging: $1,433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,775.67 |
| Education | $2,558.88 |
| Travel and Lodging | $1,432.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,949.50 | 2025 | |
| Glaxosmithkline, LLC. | $2,326.65 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $1,065.95 | 2019-2025 | Airsupra, Fasenra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $541.11 | 2019-2025 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Pulmonx Corporation | $496.01 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $372.74 | 2020-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $354.01 | 2019-2024 | |
| Insmed, INC. | $317.57 | 2019-2025 | Arikayce, Brinsupri |
| Takeda Pharmaceuticals U.S.A., INC. | $317.42 | 2020-2025 | Glassia, Hyqvia |
| Pfizer INC. | $293.01 | 2019-2024 | |
| Jazz Pharmaceuticals INC. | $289.16 | 2019-2025 | |
| Genzyme Corporation | $285.60 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $238.72 | 2019-2025 | Uptravi, Opsumit |
| Regeneron Healthcare Solutions, INC. | $185.06 | 2019-2025 | Dupixent |
| Mylan Specialty L.P. | $177.00 | 2019-2024 | Yupelri |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $156.79 | 2022-2025 | Hillrom - Volara System, Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Philips North America LLC | $147.01 | 2019-2025 | Vest Therapy Und, (O58) Sleep Respiratory Care Und |
| Sunovion Pharmaceuticals INC. | $137.71 | 2019-2020 | |
| Zoll Respicardia, INC. | $120.94 | 2024-2025 | Remede System |
| Harmony Biosciences LLC | $112.59 | 2020-2025 | |
| Amgen INC. | $111.36 | 2022-2024 | Tezspire |
| Mallinckrodt Enterprises LLC | $91.77 | 2019 | |
| Lilly USA, LLC | $91.37 | 2023-2025 | Zepbound, Jardiance |
| Boston Scientific Corporation | $87.53 | 2020-2022 | |
| Verona Pharma, INC. | $80.88 | 2025 | Ohtuvayre |
| Genentech USA, INC. | $79.40 | 2024-2025 | Xolair |
| Sanofi-Aventis U.S. LLC | $78.17 | 2019-2024 | |
| Electromed, INC. | $62.96 | 2023-2025 | Smartvest |
| Alexion Pharmaceuticals, INC. | $62.49 | 2020-2025 | Ultomiris |
| Axsome Therapeutics, INC. | $58.34 | 2024-2025 | Sunosi |
| Grifols USA, LLC | $53.18 | 2024-2025 | Prolastin-C Liquid |
| Janssen Pharmaceuticals, INC | $47.53 | 2019 | |
| Shire North American Group INC | $43.47 | 2019 | |
| Circassia INC. | $40.46 | 2019 | |
| Abbvie INC. | $36.01 | 2023-2024 | |
| Portola Pharmaceuticals, LLC | $35.80 | 2019 | |
| Inspire Medical Systems, INC. | $33.94 | 2025 | Inspire |
| Viatris Specialty LLC | $31.23 | 2025 | Yupelri |
| Phadia US INC. | $30.60 | 2022-2024 | Immunocap |
| Merck Sharp & Dohme LLC | $23.35 | 2023 | Keytruda |
| Vapotherm INC | $21.63 | 2022 | |
| Inogen, INC. | $21.18 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Resmed Corp | $20.90 | 2025 | |
| Vifor Pharma, INC. | $20.33 | 2024 | Zemaira |
| Covis Pharma Gmbh | $19.50 | 2022 | |
| Advanced Respiratory, INC | $17.63 | 2019 | |
| Ambu INC. | $11.04 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankit Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.